ALK-Abelló Croissance future
Future contrôle des critères 4/6
ALK-Abelló devrait augmenter ses bénéfices et son chiffre d'affaires de 21.5% et de 10.5% par an respectivement. Le BPA devrait croître de de 18.7% par an. Le rendement des capitaux propres devrait être 19.6% dans 3 ans.
Informations clés
21.5%
Taux de croissance des bénéfices
18.7%
Taux de croissance du BPA
| Pharmaceuticals croissance des bénéfices | 15.7% |
| Taux de croissance des recettes | 10.5% |
| Rendement futur des capitaux propres | 19.6% |
| Couverture par les analystes | Low |
| Dernière mise à jour | 15 Nov 2024 |
Mises à jour récentes de la croissance future
Results: ALK-Abelló A/S Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 17
Analysts Have Made A Financial Statement On ALK-Abelló A/S' (CPH:ALK B) Second-Quarter Report
Aug 25ALK-Abelló A/S (CPH:ALK B) Released Earnings Last Week And Analysts Lifted Their Price Target To kr.143
May 05Recent updates
Results: ALK-Abelló A/S Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 17Does ALK-Abelló (CPH:ALK B) Have A Healthy Balance Sheet?
Nov 10Calculating The Fair Value Of ALK-Abelló A/S (CPH:ALK B)
Oct 10Analysts Have Made A Financial Statement On ALK-Abelló A/S' (CPH:ALK B) Second-Quarter Report
Aug 25What You Can Learn From ALK-Abelló A/S' (CPH:ALK B) P/E
Aug 12Is ALK-Abelló (CPH:ALK B) Using Too Much Debt?
Jun 25A Look At The Intrinsic Value Of ALK-Abelló A/S (CPH:ALK B)
Jun 07ALK-Abelló A/S (CPH:ALK B) Released Earnings Last Week And Analysts Lifted Their Price Target To kr.143
May 05ALK-Abelló A/S' (CPH:ALK B) Share Price Matching Investor Opinion
Apr 27ALK-Abelló A/S (CPH:ALK B) Shares Could Be 29% Below Their Intrinsic Value Estimate
Mar 06ALK-Abelló (CPH:ALK B) Has A Pretty Healthy Balance Sheet
Jan 19With ALK-Abelló A/S (CPH:ALK B) It Looks Like You'll Get What You Pay For
Jan 01Is ALK-Abelló (CPH:ALK B) A Risky Investment?
Sep 09ALK-Abelló (CPH:ALK B) Has A Pretty Healthy Balance Sheet
Jun 11Is ALK-Abelló A/S (CPH:ALK B) Trading At A 26% Discount?
May 24ALK-Abelló (CPH:ALK B) Has A Pretty Healthy Balance Sheet
Mar 12ALK-Abelló A/S (CPH:ALK B) Shares Could Be 26% Below Their Intrinsic Value Estimate
Feb 17Investors Interested In ALK-Abelló A/S' (CPH:ALK B) Earnings
Jan 30ALK-Abelló (CPH:ALK B) Seems To Use Debt Rather Sparingly
Dec 05Is ALK-Abelló A/S (CPH:ALK B) Trading At A 32% Discount?
Nov 11Does ALK-Abelló (CPH:ALK B) Have A Healthy Balance Sheet?
Sep 01Calculating The Fair Value Of ALK-Abelló A/S (CPH:ALK B)
Aug 05We Think ALK-Abelló (CPH:ALK B) Can Manage Its Debt With Ease
May 12Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2026 | 6,872 | 1,398 | 1,018 | 1,487 | 5 |
| 12/31/2025 | 6,188 | 1,207 | 807 | 1,285 | 5 |
| 12/31/2024 | 5,560 | 860 | 446 | 853 | 5 |
| 9/30/2024 | 5,383 | 785 | 777 | 1,086 | N/A |
| 6/30/2024 | 5,180 | 690 | 724 | 1,046 | N/A |
| 3/31/2024 | 4,941 | 555 | 449 | 796 | N/A |
| 12/31/2023 | 4,824 | 486 | 288 | 667 | N/A |
| 9/30/2023 | 4,728 | 424 | 17 | 426 | N/A |
| 6/30/2023 | 4,680 | 359 | -76 | 343 | N/A |
| 3/31/2023 | 4,590 | 335 | 90 | 479 | N/A |
| 12/31/2022 | 4,511 | 335 | 63 | 416 | N/A |
| 9/30/2022 | 4,361 | 333 | 149 | 489 | N/A |
| 6/30/2022 | 4,227 | 318 | 163 | 493 | N/A |
| 3/31/2022 | 4,050 | 255 | 152 | 432 | N/A |
| 12/31/2021 | 3,916 | 219 | 205 | 468 | N/A |
| 9/30/2021 | 3,808 | 112 | 273 | 505 | N/A |
| 6/30/2021 | 3,652 | 55 | 158 | 358 | N/A |
| 3/31/2021 | 3,556 | 66 | 147 | 358 | N/A |
| 12/31/2020 | 3,491 | 25 | 79 | 301 | N/A |
| 9/30/2020 | 3,383 | 43 | 87 | 298 | N/A |
| 6/30/2020 | 3,350 | 49 | 149 | 353 | N/A |
| 3/31/2020 | 3,363 | -9 | -14 | 172 | N/A |
| 12/31/2019 | 3,274 | -50 | -35 | 132 | N/A |
| 9/30/2019 | 3,178 | -183 | -104 | 59 | N/A |
| 6/30/2019 | 3,100 | -200 | -211 | -54 | N/A |
| 3/31/2019 | 3,030 | -149 | -205 | -27 | N/A |
| 12/31/2018 | 2,915 | -170 | -273 | -95 | N/A |
| 9/30/2018 | 2,891 | -183 | -394 | -223 | N/A |
| 6/30/2018 | 2,897 | -152 | N/A | -214 | N/A |
| 3/31/2018 | 2,873 | -136 | N/A | -386 | N/A |
| 12/31/2017 | 2,910 | -158 | N/A | -387 | N/A |
| 9/30/2017 | 2,901 | 37 | N/A | -278 | N/A |
| 6/30/2017 | 2,864 | 76 | N/A | -146 | N/A |
| 3/31/2017 | 2,946 | 149 | N/A | 206 | N/A |
| 12/31/2016 | 3,005 | 270 | N/A | 405 | N/A |
| 9/30/2016 | 2,938 | 373 | N/A | 492 | N/A |
| 6/30/2016 | 2,975 | 396 | N/A | 458 | N/A |
| 3/31/2016 | 2,767 | 378 | N/A | 312 | N/A |
| 12/31/2015 | 2,569 | 344 | N/A | 183 | N/A |
| 9/30/2015 | 2,494 | 221 | N/A | 153 | N/A |
| 6/30/2015 | 2,349 | 185 | N/A | 136 | N/A |
| 3/31/2015 | 2,399 | 162 | N/A | 258 | N/A |
| 12/31/2014 | 2,433 | 181 | N/A | 320 | N/A |
| 9/30/2014 | 2,414 | 205 | N/A | 307 | N/A |
| 6/30/2014 | 2,401 | 188 | N/A | 330 | N/A |
| 3/31/2014 | 2,318 | 127 | N/A | 157 | N/A |
| 12/31/2013 | 2,244 | 61 | N/A | 146 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de ALK B ( 21.5% par an) est supérieure au taux d'épargne ( 1.2% ).
Bénéfices vs marché: Les bénéfices de ALK B ( 21.5% par an) devraient croître plus rapidement que le marché Danish ( 11.6% par an).
Croissance élevée des bénéfices: Les bénéfices de ALK B devraient augmenter de manière significative au cours des 3 prochaines années.
Chiffre d'affaires vs marché: Le chiffre d'affaires de ALK B ( 10.5% par an) devrait croître plus rapidement que le marché Danish ( 10% par an).
Croissance élevée des revenus: Le chiffre d'affaires de ALK B ( 10.5% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de ALK B devrait être faible dans 3 ans ( 19.6 %).